Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Unprotected Left Main Disease - A Review

Login or register to view PDF.
Abstract

There have been over a dozen studies in the drug-eluting stent era comparing the effectiveness of percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery for the treatment of unprotected left main disease. These studies have been both randomised and observational in nature. While both methodologies provide important insights, careful consideration of their respective strengths and limitations is imperative in generalising their findings.

Disclosure
The author receives research funding from the National Institutes of Health and from the Kaiser Foundation Research Institute; no relations with industry.
Correspondence
Edward McNulty, Kaiser Permanente Medical Center, 2200 O'Farrell Street, San Francisco, CA 94115, US. E: edward.j.mcnulty@kp.org
Received date
21 October 2012
Accepted date
18 January 2013
Citation
Interventional Cardiology Review 2013;8(1):14–8
DOI
http://dx.doi.org/10.15420/icr.2013.8.1.14
References
  1. Wijns W, Kolh P, Danchin N, et al., Guidelines on myocardial revascularization, Eur Heart J, 2010;31:2501–55.
    Crossref | PubMed
  2. Levine GN, Bates ER, Blankenship JC, et al., 2011 ACCF/AHA/ SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, J Am Coll Cardiol, 2011;58:2550–83.
  3. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group, N Engl J Med, 1984;311:1333–9.
    Crossref | PubMed
  4. Varnauskas E, Twelve-year follow-up of survival in the randomized European Coronary Surgery Study, N Engl J Med, 1988;319:332–7.
    Crossref | PubMed
  5. Yusuf S, Zucker D, Peduzzi P, et al., Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration, Lancet, 1994;344:563–70.
    Crossref | PubMed
  6. Chaitman BR, Fisher LD, Bourassa MG, et al., Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS), Am J Cardiol, 1981;48:765–77.
    Crossref | PubMed
  7. Pocock SJ, Assmann SE, Enos LE, Kasten LE, Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems, Stat Med, 2002;21:2917–30.
    Crossref | PubMed
  8. Van Spall HG, Toren A, Kiss A, Fowler RA, Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review, JAMA, 2007;297:1233–40.
    Crossref | PubMed
  9. Jones EL, King SB 3rd, Craver JM, et al., The spectrum of left main coronary artery disease: variables affecting patient selection, management, and death, J Thorac Cardiovasc Surg, 1980;79:109–16.
    PubMed
  10. Huang HW, Brent BN, Shaw RE, Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR, Catheter Cardiovasc Interv, 2006;68:867–72.
    Crossref | PubMed
  11. Palmerini T, Marzocchi A, Marrozzini C, et al., Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry), Am J Cardiol, 2006;98:54–9.
    Crossref | PubMed
  12. Sanmartin M, Baz JA, Claro R, et al., Comparison of drugeluting stents versus surgery for unprotected left main coronary artery disease, Am J Cardiol, 2007;100:970–3.
    Crossref
  13. Brener SJ, Galla JM, Bryant R 3rd, et al., Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients, Am J Cardiol, 2008;101:169–72.
    Crossref | PubMed
  14. Wu C, Hannan EL, Walford G, Faxon DP, Utilization and outcomes of unprotected left main coronary artery stenting and coronary artery bypass graft surgery, Ann Thorac Surg, 2008;86:1153–9.
    Crossref | PubMed
  15. Mäkikallio TH, Niemelä M, Kervinen K, et al., Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting, Ann Med, 2008;40:437–43.
    Crossref | PubMed
  16. White AJ, Kedia G, Mirocha JM, et al., Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis, JACC Cardiovasc Interv, 2008;1:236–45.
    Crossref | PubMed
  17. Rodés-Cabau J, Deblois J, Bertrand OF, et al., Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians, Circulation, 2008;118:2374–81.
    Crossref | PubMed
  18. Park DW, Seung KB, Kim YH, et al., Long-term safety and effiacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry, J Am Coll Cardiol, 2010;56:117–24.
    Crossref | PubMed
  19. Kang SH, Park KH, Choi DJ, et al., Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry), Am J Cardiol, 2010;105:343–51.
    Crossref | PubMed
  20. Chieffo A, Magni V, Latib A, et al., 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience, JACC Cardiovasc Interv, 2010;3:595–601.
    Crossref | PubMed
  21. Capodanno D, Caggegi A, Capranzano P, et al., Validating the EXCEL hypothesis: a propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32, Catheter Cardiovasc Interv, 2011;77:936–43.
    Crossref | PubMed
  22. Lee MS, Yang T, Dhoot J, Liao H, Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings, Am J Cardiol, 2010;105:1070–5.
    Crossref | PubMed
  23. Naik H, White AJ, Chakravarty T, et al., A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis, JACC Cardiovasc Interv, 2009;2:739–47.
    Crossref | PubMed
  24. Yeh RW, Mauri L, Choosing methods to minimize confounding in observational studies: do the ends justify the means?, Circ Cardiovasc Qual Outcomes, 2011;4:581–3.
    Crossref | PubMed
  25. McNulty EJ, Ng W, Spertus JA, et al., Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies, JACC Cardiovasc Interv, 2011;4:1020–7.
    Crossref | PubMed
  26. Buszman PE, Kiesz SR, Bochenek A, et al., Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization, J Am Coll Cardiol, 2008;51:538–45.
    Crossref | PubMed
  27. Boudriot E, Thiele H, Walther T, et al., Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis, J Am Coll Cardiol, 2011;57:538–45.
    Crossref | PubMed
  28. Park SJ, Kim YH, Park DW, et al., Randomized trial of stents versus bypass surgery for left main coronary artery disease, N Engl J Med, 2011;364:1718–27.
    Crossref | PubMed
  29. Kappetein AP, Feldman TE, Mack MJ, et al., Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial, Eur Heart J, 2011;32:2125–34.
    Crossref | PubMed
  30. Capodanno D, Stone GW, Morice MC, et al., Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data, J Am Coll Cardiol, 2011;58:1426–32.
    Crossref | PubMed
  31. Kaul S, Diamond GA, Trial and error. How to avoid commonly encountered limitations of published clinical trials, J Am Coll Cardiol, 2010;55:415–27.
    Crossref | PubMed
  32. Cohen DJ, Van Hout B, Serruys PW, et al., Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery, N Engl J Med, 2011;364:1016–26.
    Crossref | PubMed
  33. Sianos G, Morel MA, Kappetein AP, et al., The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease, EuroIntervention, 2005;1:219–27.
    PubMed
  34. Palmerini T, Sangiorgi D, Marzocchi A, et al., Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology, Eur Heart J, 2009;30:2087–94.
    Crossref | PubMed
  35. Chen SL, Ye F, Zhang JJ, et al., Distal left main coronary bifurcation lesions predict worse outcome in patients undergoing percutaneous implantation of drug-eluting stents: results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study, Cardiology, 2009;113:264–73.
    Crossref | PubMed
  36. Garg S, Stone GW, Kappetein AP, et al., Clinical and angiographic risk assessment in patients with left main stem lesions, JACC Cardiovasc Interv, 2010;3:891–901.
    Crossref | PubMed
  37. Lindstaedt M, Spiecker M, Perings C, et al., How good are experienced interventional cardiologists at predicting the functional signifiance of intermediate or equivocal l eft main coronary artery stenoses?, Int J Cardiol, 2007;120:254–61.
    Crossref | PubMed
  38. Hamilos M, Muller O, Cuisset T, et al., Long-term clinical outcome after fractional flw reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis, Circulation, 2009;120:1505–12.
    Crossref | PubMed
  39. Caracciolo EA, Davis KB, Sopko G, et al., Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience, Circulation, 1995;91:2325–34.
    Crossref | PubMed
  40. de la Torre Hernandez JM, Hernández Hernandez F, Alfonso F, et al., Prospective application of pre-defied intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study, J Am Coll Cardiol, 2011;58:351–8.
    Crossref | PubMed
  41. Holmes DR Jr, Mohr F, Hamm CW, Mack MJ, Venn diagrams in cardiovascular disease: the Heart Team concept, Ann Thorac Surg, 2013;95:389–91.
    Crossref | PubMed
  42. Hannan EL, Racz MJ, Gold J, et al., Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice?, Circulation, 2010;121:267–75.
    Crossref | PubMed
  43. Claessen BE, Stone GW, Smits PC, et al., Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?: A meta-analysis of a fist-generation vs. a second-generation drug-eluting stent system, Neth Heart J, 2010;18:451–3.
    Crossref | PubMed